Reuters logo
BRIEF-Pacira Pharmaceuticals Inc reports Q1 GAAP loss per share $0.52
May 4, 2017 / 12:14 PM / 5 months ago

BRIEF-Pacira Pharmaceuticals Inc reports Q1 GAAP loss per share $0.52

May 4 (Reuters) - Pacira Pharmaceuticals Inc:

* Pacira pharmaceuticals, inc. Reports first quarter 2017 financial results

* Q1 non-GAAP loss per share $0.19

* Q1 GAAP loss per share $0.52

* Q1 revenue $69.3 million versus I/B/E/S view $70.3 million

* Q1 earnings per share view $-0.04 -- Thomson Reuters I/B/E/S

* Says reaffirms FY 2017 exparel net product sales guidance of $290 million to $310 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below